Non-alcoholic fatty liver disease (NAFLD) is the first cause of chronic liver disease
worldwide; it ranges from simple steatosis to steatohepatitis (NASH) and, potentially …

There has been a growing interest in the role of vitamin E supplementation in the treatment
and/or prevention of nonalcoholic fatty liver (NAFLD). We performed a systematic review of …

The results of randomized controlled trials (RCTs) investigating supplemental vitamin D on
aminotransferases and cardio-metabolic risk factors in subjects with non-alcoholic fatty liver …

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease.
NAFLD often occurs associated with endocrinopathies. Evidence suggests that endocrine …

Background Vitamin D deficiency is often reported in people with chronic liver diseases.
Improving vitamin D status could therefore be beneficial for people with chronic liver …

Background: Vitamin D was reported to be associated with non− alcoholic fatty liver disease
(NAFLD). This systematic review and meta− analysis aimed to investigate the effects of the …

The evidence relating either lower vitamin D status to the prevalence and severity of NAFLD,
or examining vitamin D supplementation in patients with NAFLD is inconclusive. Larger …

Abstract Background & Aims Non‐alcoholic fatty liver disease (NAFLD) is the most common
chronic liver disease worldwide and an independent risk factor for cardiovascular mortality …

The flexibility between the wide array of hepatic functions relies on calcium (Ca 2+)
signalling. Indeed, Ca 2+ is implicated in the control of many intracellular functions as well …

代谢相关脂肪性肝病(MAFLD) 为全球第一大慢性肝病, 但发病机制仍不明确,
尚缺乏有效的治疗药物. 介绍了MAFLD 患者常伴有维生素D 缺乏, 维生素D …